These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 265392)

  • 41. [Toxicology of fluorescein].
    Miyata M; Tanaka K; Mizuno K
    Nippon Ganka Gakkai Zasshi; 1972 Dec; 76(12):1601-7. PubMed ID: 4676035
    [No Abstract]   [Full Text] [Related]  

  • 42. [Daily use of dental plaque disclosing material].
    Schouker M
    Prev Stomatol; 1980; 6(4):25-6. PubMed ID: 6938946
    [No Abstract]   [Full Text] [Related]  

  • 43. A fluorescent plaque disclosing agent.
    Lang NP; Ostergaard E; Löe H
    J Periodontal Res; 1972; 7(1):59-67. PubMed ID: 4272033
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of action of a two-tone plaque disclosing agent.
    Gallagher IH; Fussell SJ; Cutress TW
    J Periodontol; 1977 Jul; 48(7):395-6. PubMed ID: 69704
    [No Abstract]   [Full Text] [Related]  

  • 45. Ceplak disclosing tablets--an aid for oral hygiene.
    Schienbein H
    Quintessence Int Dent Dig; 1973 Mar; 4(3):29-33. PubMed ID: 4514086
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of plaque-staining agents].
    Kardel KM; Bay I
    Tandlaegebladet; 1967 Jan; 71(1):3-8. PubMed ID: 5264794
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibacterial activity of some plaque-disclosing agents and dyes.
    Marsh PD; Bevis RA; Newman HN; Hallsworth AS; Robinson C; Weatherell JA; Pitter AF
    Caries Res; 1989; 23(5):348-50. PubMed ID: 2548723
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of the teratogenicity of fluorescein sodium.
    McEnerney JK; Wong WP; Peyman GA
    Am J Ophthalmol; 1977 Dec; 84(6):847-50. PubMed ID: 596400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A two-tone dye test for dental plaque.
    Block PL; Lobene RR; Derdivanis JP
    J Periodontol; 1972 Jul; 43(7):423-6. PubMed ID: 4504527
    [No Abstract]   [Full Text] [Related]  

  • 50. Monitoring of the generation of non-mutagenic benzoic acid compounds during the manufacture of erythrosine.
    Wada K; Fujita T; Ogawa Y; Koda T; Aoki H
    Food Addit Contam; 2004 Dec; 21(12):1137-48. PubMed ID: 15799558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coacervation of alkyltrimethylammonium bromides by tartrazine, amaranth, carmoisine, and erythrosine.
    Barry BW; Gray GM
    J Pharm Sci; 1974 Apr; 63(4):548-59. PubMed ID: 4828703
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of bacterial plaque disclosants in periodontal disease.
    Cohen DW; Stoller NH; Chace R; Laster L
    J Periodontol; 1972 Jun; 43(6):333-8. PubMed ID: 4504184
    [No Abstract]   [Full Text] [Related]  

  • 53. High-performance liquid chromatographic determination of subsidiary dyes, intermediates and side reaction products in erythrosine.
    Lancaster FE; Lawrence JF
    J Chromatogr; 1987 Feb; 388(1):248-52. PubMed ID: 3031104
    [No Abstract]   [Full Text] [Related]  

  • 54. Photosensitization eczema with positive erythrosine test.
    Castelain PY; Piriou A
    Contact Dermatitis; 1978 Oct; 4(5):305. PubMed ID: 754711
    [No Abstract]   [Full Text] [Related]  

  • 55. [What are plaque dyes?].
    Petersen JK
    Tandlaegebladet; 1975 Jun; 79(10):403-7. PubMed ID: 1077977
    [No Abstract]   [Full Text] [Related]  

  • 56. The value of 2,4-Bis(N,N'-Di(carboxymethyl) aminomethyl) fluorescein as a bone marking dye.
    Sullivan PG
    Arch Oral Biol; 1972 Oct; 17(10):1487-9. PubMed ID: 4117251
    [No Abstract]   [Full Text] [Related]  

  • 57. [Intravenous pancreatography with erythrosine B in human clinical practice. Study of 30 initial cases].
    Ledoux-Lebard G; Heitz F; Béhar A; Rosier J; Leger L; Siguier F
    Presse Med (1893); 1967 Sep; 75(39):1943-6. PubMed ID: 6053124
    [No Abstract]   [Full Text] [Related]  

  • 58. A predictive model for estimating rat oral LD50 values.
    Enslein K; Lander TR; Tomb ME; Craig PN
    Toxicol Ind Health; 1989 Mar; 5(2):261-387. PubMed ID: 2728019
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical and Experimental Studies of Fluorescein Dyes with Special Reference to their Use for the Diagnosis of Central Nervous System Tumors.
    Moore GE; Hunter SW; Hubbard TB
    Ann Surg; 1949 Oct; 130(4):637-42. PubMed ID: 17859457
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of fluorescein dyes in the diagnosis of malignancy with special reference to tumors of the central nervous system.
    HUBBARD TB; MOORE GE
    J Natl Cancer Inst; 1949 Oct; 10(2):303-14. PubMed ID: 15393715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.